The Molecular Neurobiology of Depression

Psychiatric Clinics of North America

Volumn 30, Issue 1, 2007, Pages 1-11

  Shelton, Richard C ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SEROTONIN TRANSPORTER;

ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; DEPRESSION; ENVIRONMENTAL STRESS; GENOTYPE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MELANCHOLIA; NERVE CELL PLASTICITY; NEUROBIOLOGY; OXIDATION REDUCTION POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; SEROTONIN; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 33847691902     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2006.12.005     Document Type: Review

References (66)

1. Gillespie C.F., and Nemeroff C.B. Hypercortisolemia and depression. Psychosom Med 67 Suppl 1 (2005) S26-S28
2. Hayley S., Poulter M.O., Merali Z., et al. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135 3 (2005) 659-678
3. Kendler K.S., Davis C.G., and Kessler R.C. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry 170 (1997) 541-548
4. Kendler K.S., Kessler R.C., Walters E.E., et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 153 (1995) 833-842
5. Shelton R.C., Manier D.H., Peterson C.S., et al. Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharmacol 2 3 (1999) 187-192
6. Dwivedi Y., Conley R.R., Roberts R.C., et al. [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry 159 1 (2002) 66-73
7. Dwivedi Y., Rizavi H.S., Shukla P.K., et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 55 3 (2004) 234-243
8. Shelton R.C. Intracellular mechanisms of antidepressant drug action. Harv Rev Psychiatry 8 4 (2000) 161-174
9. Kendler K.S., Gardner C.O., and Prescott C.A. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 159 7 (2002) 1133-1145
10. Kendler K.S., Gardner C.O., and Prescott C.A. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry 163 1 (2006) 115-124
11. Kendler K.S., Kuhn J.W., and Prescott C.A. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 34 8 (2004) 1475-1482
12. Kendler K.S., Sheth K., Gardner C.O., et al. Childhood parental loss and risk for first-onset of major depression and alcohol dependence: the time-decay of risk and sex differences. Psychol Med 32 7 (2002) 1187-1194
13. Kendler K.S., Thornton L.M., and Gardner C.O. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 158 4 (2001) 582-586
14. Kendler K.S., Thornton L.M., and Gardner C.O. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry 157 8 (2000) 1243-1251
15. Caspi A., Sugden K., Moffitt T.E., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 5631 (2003) 386-389
16. Kendler K.S., Kuhn J.W., Vittum J., et al. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62 5 (2005) 529-535
17. Heim C., Plotsky P.M., and Nemeroff C.B. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29 4 (2004) 641-648
18. Nemeroff C.B. Neurobiological consequences of childhood trauma. J Clin Psychiatry 65 Suppl 1 (2004) 18-28
19. Wong M.-L., Kling M.A., and Munson P.J. Pronounced and sustained central hypernoradrenergic function in mahor depression with melancholic features: relation to hypercortisolism and corticotrophin-releasing hormone. Proc Natl Acad Sci U S A 97 (2000) 325-330
20. Gold P.W., Drevets W.C., and Charney D.S. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 52 5 (2002) 381-385
21. Heuser I., Bissette G., Dettling M., et al. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety 8 2 (1998) 71-79
22. Banki C.M., Karmacsi L., Bissette G., et al. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 2 2 (1992) 107-113
23. Nestler E.J., and Greengard P. Protein phosphorylation in the nervous system (1984), John Wiley & Sons, New York
24. Hyman S.E., and Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153 2 (1996) 151-162
25. Yamamoto K.K., Gonzalez G.A., Biggs III W.H., et al. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334 6182 (1988) 494-498
26. Pandey G.N., and Dwivedi Y. Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide. Int J Neuropsychopharmacol 8 (2005) 1-4
27. 2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology 29 (2004) 2081-2087
28. Akin D., Manier D.H., Sanders-Bush E., et al. Signal transduction abnormalities in melancholic depression. Int J Neuropsychopharmacol 8 (2005) 5-16
29. Manier D.H., Shelton R.C., Ellis T.C., et al. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 61 1-2 (2000) 51-58
30. Shelton R.C., Liang S., Liang P., et al. Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Neuropsychopharmacology 29 (2004) 126-132
31. Pandey G.N., Dwivedi Y., Pandey S.C., et al. Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci Lett 228 2 (1997) 111-114
32. Pandey G.N., Dwivedi Y., Kumari R., et al. Protein kinase C in platelets of depressed patients. Biol Psychiatry 44 (1998) 909-911
33. Pandey G.N., Dwivedi Y., SridharaRao J., et al. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 26 2 (2002) 216-228
34. Dwivedi Y., Rao J.S., Rizavi H.S., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 60 3 (2003) 273-282
35. Pandey GN, Dwivedi Y, Ren X, et al. Decreased protein expression and CRE-DNA binding activity of cyclic adenosine monophosphate response element binding protein in neutrophil of depressed patients. Presented at the annual meeting of the American College of Neuropsychopharmacology. San Juan, PR; December 7-11, 2003.
36. Hrdina P., Faludi G., Li Q., et al. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol Psychiatry 3 5 (1998) 411-418
37. Coull M.A., Lowther S., Katona C.L., et al. Altered brain protein kinase C in depression: a post-mortem study. Eur Neuropsychopharmacol 10 4 (2000) 283-288
38. Perez J., Tardito D., Racagni G., et al. Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol Psychiatry 6 1 (2001) 44-49
39. Perez J., Tardito D., Racagni G., et al. cAMP signaling pathway in depressed patients with psychotic features. Mol Psychiatry 7 2 (2002) 208-212
40. Shieh P.B., Hu S.C., Bobb K., et al. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20 4 (1998) 727-740
41. Meller R., Babity J.M., and Grahame-Smith D.G. 5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells. NeuroMolecular Med 1 3 (2002) 197-205
42. Karege F., Schwald M., and El Kouaissi R. Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder. Neuropsychopharmacology 29 4 (2004) 805-812
43. Deogracias R., Espliguero G., Iglesias T., et al. Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol Cell Neurosci 26 3 (2004) 470-480
44. Barrett T.J., and Vedeckis W.V. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types. Recept Signal Transduct 6 3-4 (1996) 179-193
45. Malkoski S.P., and Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol 13 10 (1999) 1629-1644
46. Qi M., Zhuo M., Skalhegg B.S., et al. Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 93 4 (1996) 1571-1576
47. Dempsey E.C., Newton A.C., Mochly-Rosen D., et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279 3 (2000) L429-L438
48. Nguyen P.V., and Woo N.H. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol 71 6 (2003) 401-437
49. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry 7 Suppl 1 (2002) S29-S34
50. Adler V., Yin Z., Tew K.D., et al. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18 45 (1999) 6104-6111
51. Dickinson D.A., Moellering D.R., Iles K.E., et al. Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 384 4 (2003) 527-537
52. Dickinson D.A., and Forman H.J. Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 973 (2002) 488-504
53. Humphries K.M., Juliano C., and Taylor S.S. Regulation of cAMP-dependent protein kinase activity by glutathionylation. J Biol Chem 277 45 (2002) 43505-43511
54. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. [review] [92 refs]. Mol Psychiatry 4 4 (1999) 317-327
55. Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol 16 1 (2001) 95-103
56. Maes M., Kenis G., Kubera M., et al. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. Int Immunopharmacol 5 3 (2005) 609-618
57. Jenuwein T., and Allis C.D. Translating the histone code. [See comment]. Science 293 5532 (2001) 1074-1080
58. Egger G., Liang G., Aparicio A., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 (2004) 457-463
59. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. [review] [186 refs]. Nat Genet 33 Suppl (2003) 54
60. Champagne F.A., Weaver I.C., Diorio J., et al. Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 147 (2006) 2909-2915
61. Weaver I.C., Champagne F.A., Brown S.E., et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25 (2005) 11045-11054
62. Szyf M., Weaver I.C., Champagne F.A., et al. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol 26 (2005) 139-162
63. Meaney M.J., and Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7 (2005) 103-123
64. Fish E.W., Shahrokh D., Bagot R., et al. Epigenetic programming of stress responses through variations in maternal care. Ann N Y Acad Sci 1036 (2004) 167-180
65. Weaver I.C., Cervoni N., Champagne F.A., et al. Epigenetic programming by maternal behavior. Nat Neurosci 7 (2004) 847-854
66. Weaver I.C., Szyf M., and Meaney M.J. From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocr Res 28 (2002) 699